Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC | 293,609 | reported | 19 Mar 2026 | tx 58+8,149,225−3,924,756 |
| Ra Pharmaceuticals, Inc. | 15,000 | reported | 20 Jun 2017 | tx 21+4,064,701−25,212,694 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Mar 2026 | SALE | ALX ONCOLOGY HOLDINGS INC | 12,311 | 2.17 USD | |
| 17 Feb 2026 | TAX_WITHHOLDING | ALX ONCOLOGY HOLDINGS INC | 2,201 | 2.27 USD | |
| 26 Jan 2026 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 912,000 | 0.00 USD | deriv |
| 14 Oct 2025 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 597,500 | 0.00 USD | deriv |
| 17 Sept 2025 | PURCHASE | ALX ONCOLOGY HOLDINGS INC | 71,163 | 1.08 USD | |
| 16 Sept 2025 | PURCHASE | ALX ONCOLOGY HOLDINGS INC | 21,070 | 1.07 USD | first after silence |
| 15 Aug 2025 | SALE | ALX ONCOLOGY HOLDINGS INC | 2,382 | 0.64 USD | |
| 11 Apr 2025 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 125,000 | 0.00 USD | deriv |
| 14 Mar 2025 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 42,000 | 0.00 USD | |
| 19 Feb 2025 | SALE | ALX ONCOLOGY HOLDINGS INC | 2,159 | 1.15 USD | |
| 21 Jan 2025 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 478,000 | 0.00 USD | deriv |
| 02 Dec 2024 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 200,000 | 0.00 USD | deriv |
| 14 Aug 2024 | TAX_WITHHOLDING | ALX ONCOLOGY HOLDINGS INC | 2,191 | 2.58 USD | |
| 14 Mar 2024 | PURCHASE | ALX ONCOLOGY HOLDINGS INC | 4,400 | 11.31 USD | first after silence |
| 14 Feb 2024 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 60,000 | 0.00 USD | |
| 14 Feb 2024 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 190,000 | 0.00 USD | deriv |
| 08 Sept 2023 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 1,200,000 | 0.00 USD | deriv |
| 20 Jun 2023 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 20,200 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | ALX ONCOLOGY HOLDINGS INC | 12,004 | 0.00 USD | deriv |
| 08 Dec 2021 | SALE | ALX ONCOLOGY HOLDINGS INC | 4,883 | 33.23 USD | |
| 08 Dec 2021 | SALE | ALX ONCOLOGY HOLDINGS INC | 35,836 | 33.23 USD | |
| 08 Dec 2021 | SALE | ALX ONCOLOGY HOLDINGS INC | 208 | 33.80 USD | |
| 09 Dec 2021 | SALE | ALX ONCOLOGY HOLDINGS INC | 11,452 | 31.08 USD | |
| 09 Dec 2021 | SALE | ALX ONCOLOGY HOLDINGS INC | 1,560 | 31.08 USD | |
| 09 Dec 2021 | SALE | ALX ONCOLOGY HOLDINGS INC | 42,203 | 32.06 USD |
3 purchases reported after at least 12 months of silence — most recent on 16 Sept 2025.